BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23332037)

  • 1. Are treatment benefits in neuropathic pain reflected in the Self Assessment of Treatment questionnaire?
    Wiklund I; Holmstrom S; Stoker M; Wyrwich KW; Devine M
    Health Qual Life Outcomes; 2013 Jan; 11():8. PubMed ID: 23332037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living with chronic neuropathic pain after spinal cord injury: an interpretative phenomenological analysis of community experience.
    Hearn JH; Cotter I; Fine P; A Finlay K
    Disabil Rehabil; 2015; 37(23):2203-11. PubMed ID: 25601144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT.
    Tesfaye S; Sloan G; Petrie J; White D; Bradburn M; Young T; Rajbhandari S; Sharma S; Rayman G; Gouni R; Alam U; Julious SA; Cooper C; Loban A; Sutherland K; Glover R; Waterhouse S; Turton E; Horspool M; Gandhi R; Maguire D; Jude E; Ahmed SH; Vas P; Hariman C; McDougall C; Devers M; Tsatlidis V; Johnson M; Bouhassira D; Bennett DL; Selvarajah D
    Health Technol Assess; 2022 Oct; 26(39):1-100. PubMed ID: 36259684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
    Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "But I know what works"--patients' experience of spinal cord injury neuropathic pain management.
    Löfgren M; Norrbrink C
    Disabil Rehabil; 2012; 34(25):2139-47. PubMed ID: 22512334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, prospective study of efficacy and safety of oral tramadol in the management of post-herpetic neuralgia in patients from north India.
    Saxena AK; Nasare N; Jain S; Dhakate G; Ahmed RS; Bhattacharya SN; Mediratta PK; Banerjee BD
    Pain Pract; 2013 Apr; 13(4):264-75. PubMed ID: 22882673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It just feels weird!: a qualitative study of how children aged 10-18 years describe neuropathic pain.
    Yeung KK; Engle L; Rabel A; Adamson K; Schwellnus H; Evans C
    Disabil Rehabil; 2017 Aug; 39(17):1695-1702. PubMed ID: 27684213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term quality of life improvement for chronic intractable back and leg pain patients using spinal cord stimulation: 12-month results from the SENZA-RCT.
    Amirdelfan K; Yu C; Doust MW; Gliner BE; Morgan DM; Kapural L; Vallejo R; Sitzman BT; Yearwood TL; Bundschu R; Yang T; Benyamin R; Burgher AH; Brooks ES; Powell AA; Subbaroyan J
    Qual Life Res; 2018 Aug; 27(8):2035-2044. PubMed ID: 29858746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PROMIS Measure of Neuropathic Pain Quality.
    Askew RL; Cook KF; Keefe FJ; Nowinski CJ; Cella D; Revicki DA; Morgan DeWitt EM; Michaud K; Trence DL; Amtmann D
    Value Health; 2016; 19(5):623-30. PubMed ID: 27565279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Pretesting of a Questionnaire to Assess Patient Experiences and Satisfaction with Medications (PESaM Questionnaire).
    Kimman ML; Rotteveel AH; Wijsenbeek M; Mostard R; Tak NC; van Jaarsveld X; Storm M; Wijnsma KL; Gelens M; van de Kar NCAJ; Wetzels J; Dirksen CD
    Patient; 2017 Oct; 10(5):629-642. PubMed ID: 28357591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic pain patients' treatment preferences: a discrete-choice experiment.
    Mühlbacher AC; Junker U; Juhnke C; Stemmler E; Kohlmann T; Leverkus F; Nübling M
    Eur J Health Econ; 2015 Jul; 16(6):613-28. PubMed ID: 24950770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy.
    O'Connor AB
    Pharmacoeconomics; 2009; 27(2):95-112. PubMed ID: 19254044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
    Perrot S; Lantéri-Minet M
    Eur J Pain; 2019 Jul; 23(6):1117-1128. PubMed ID: 30793414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Mini-invasive Approach to the Treatment of Neuropathic Pain: The PENS Study.
    Rossi M; DeCarolis G; Liberatoscioli G; Iemma D; Nosella P; Nardi LF
    Pain Physician; 2016 Jan; 19(1):E121-8. PubMed ID: 26752480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
    Stokes J; Evans CJ; Pompilus F; Shields AL; Summers KH
    Patient; 2013; 6(4):291-305. PubMed ID: 24062234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer.
    Smith EM; Bakitas MA; Homel P; Piehl M; Kingman L; Fadul CE; Bookbinder M
    J Pain Symptom Manage; 2011 Dec; 42(6):822-38. PubMed ID: 21820851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.
    Gu NY; Bell C; Botteman MF; Ji X; Carter JA; van Hout B
    Patient; 2012; 5(3):185-97. PubMed ID: 22765255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact on health-related quality of life and costs of managing chronic neuropathic pain in academic pain centres: Results from a one-year prospective observational Canadian study.
    Tarride JE; Moulin DE; Lynch M; Clark AJ; Stitt L; Gordon A; Morley-Forster PK; Nathan H; Smyth C; Toth C; Ware MA
    Pain Res Manag; 2015; 20(6):327-33. PubMed ID: 26474381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.